0.9% Sodium Chloride Injection/ Intravenous Infusion

Name: 0.9% Sodium Chloride Injection/ Intravenous Infusion
Brand: Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
SKU: 753312402

Hebei, ChinaShijiazhuang No. 4 Pharmaceutical Co., Ltd.

US$0.10-0.20

10,000 Pieces

Sample price:US$0.00/piece.Request sample

Product profile

Customization

Available

Application

Internal Medicine

Usage Mode

Model NO.

100mlPP Bottle

Suitable for

Elderly, Children, Adult

State

Injection

Shape

Infusion

Type

Organic Chemicals

Pharmaceutical Technology

Chemical Synthesis

Drug Reg./Approval No.

H13023036

Production Line

GMP Approved

Transport Package

25 Bottles /Box

Specification

500ml: 4.5g

Trademark

SHIMEN

Origin

China

Company profile

Shijiazhuang No. 4 Pharmaceutical Co., Ltd.

Hebei, China

Business Type: Manufacturer/FactoryExport Year: 2002-01-01Nearest Port: Tianjin Xingang, Qingdao, ShanghaiAverage Response Time: ≤24hTerms of Payment: LC, T/TInternational Commercial Terms(Incoterms): FOB, CFR, CIF, CIP, EXW

AI-Powered supplier vetting

SummaryShijiazhuang No. 4 Pharmaceutical Co., Ltd. is a large, public pharmaceutical manufacturer based in Hebei, China. The company excels in producing infusion solutions and other pharmaceutical products, with advanced production lines and adherence to GMP standards. It holds ISO and GMP certifications, indicating a strong commitment to quality. The company has been exporting since 2002, with a portion of its sales derived from exports. It emphasizes innovation and customer satisfaction, with a growing reputation and numerous industry awards. However, specific details on financial credibility and customization capabilities are not fully disclosed.

Supplier typeShijiazhuang No. 4 Pharmaceutical Co., Ltd. is a large integrated pharmaceutical enterprise, engaging in manufacturing, R&D, and marketing.

CertificationsThe supplier holds ISO 9001, ISO 14001, and GMP certifications, indicating adherence to international management, environmental, and production standards.

After-Sales capabilityThe supplier emphasizes providing superior service concepts and measures, ensuring product quality and patient health.

R&D capabilityThe company integrates advanced technology into its production and emphasizes continuous improvement, indicating strong innovation capabilities.

Production capacityThe supplier has a large-scale production capacity with advanced lines for various pharmaceutical products, leading in the domestic market.

Send Inquiry

*To:

Shijiazhuang No. 4 Pharmaceutical Co., Ltd.

*Content:

0/4000

Supplier replies will be sent to your registered email

0.9% Sodium Chloride Injection/ Intravenous Infusion